Grace Therapeutics (GRCE) Other Working Capital Changes (2023)

Grace Therapeutics has disclosed Other Working Capital Changes across 1 years of filings, most recently posting -$10000.0 for Q3 2023.

• In Q3 2023, Other Working Capital Changes rose 220.67% year-over-year to $4.5 million; the TTM figure through Sep 2023 stood at $2.2 million (up 1124.06% YoY), while the FY2023 annual figure was -$181000.0, down 106.5% from the prior year.
• Other Working Capital Changes came in at $4.5 million for Q3 2023 at Grace Therapeutics, up from -$2.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $4.5 million in Q3 2023 to a low of -$2.0 million in Q2 2023.
• Average Other Working Capital Changes over 5 years is $784555.6, with a median of $625000.0 recorded in 2021.
• Year-over-year, Other Working Capital Changes soared 502.39% in 2020 and slumped 338.46% in 2022.
• Over 5 years, Other Working Capital Changes stood at $2.0 million in 2019, then gained by 0.05% to $2.0 million in 2020, then slumped by 65.99% to $683000.0 in 2021, then plunged by 94.88% to $35000.0 in 2022, then jumped by 12800.0% to $4.5 million in 2023.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $4.5 million in Q3 2023, -$2.0 million in Q2 2023, and -$353000.0 in Q1 2023.